EGFR and colorectal carcinoma: To explore the mechanism by which AZ304 and its combination with Cetuximab inhibit cancer cell proliferation, EGFR and its downstream signalling pathways were evaluated after treatment with AZ304 and/or Cetuximab of four CRC cell lines.